Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
475.60    5.00 (1.06%)
Bid:
473.20
Ask:
473.80
Spread: 0.60 (0.127%)
Market Cap: £2.45b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Directorate Change

21 Oct 2024 08:00

RNS Number : 8261I
QinetiQ Group plc
21 October 2024
 

QinetiQ Group plc

Non-Executive Directorate Change

 

21 October 2024 - QinetiQ Group plc ("QinetiQ" or the "Group") is pleased to announce the appointment of Dr. Ezinne Uzo-Okoro as an independent Non-Executive Director of the Board with effect from 1 November 2024. Upon appointment she will become a member of the Audit, Nominations, Remuneration and Risk & Security Committees.

Ezinne has had more than 20 years of US government service, most recently as Assistant Director at the White House Office of Science and Technology Policy from 2021 to 2024, where she had overall responsibility for Space Policy. She is now a Senior Fellow of the Belfer Center at Harvard, a Venture Partner at SineWave Ventures and serves as a term member of the Council on US Foreign Relations. 

Neil Johnson, Group Chair of QinetiQ, said:

"I am delighted to welcome Ezinne to the QinetiQ Board. She is an accomplished leader who brings a wealth of relevant expertise in national government operations in the United States. This combined with her deep knowledge in technological leadership will bring complementary experience to the Board, enhancing our contribution to QinetiQ's future success."

9.6.11R and 9.6.13R of the Listing Rules of the UK Listing Authority:

This notice is given in fulfilment of the obligation under paragraph 9.6.11R of the Listing Rules. There are no further details that are required to be disclosed in respect of Ezinne Uzo-Okoro's appointment under paragraph 9.6.13R of the Listing Rules.

 

Ezinne Uzo-Okoro biography

In 20 years of US government service, including a final tour at the White House from 2021 - 2024 as head of Space Policy, Ezinne's career has included contributions to US national policy and more than 60 NASA missions and programmes. Her work has resulted in strategies for US technological leadership and future economic growth. She is now a Senior Fellow at the Belfer Center, and a Venture Partner in SineWave, a venture capital fund focused on early-stage technology enterprises.

She earned an undergraduate degree in Computer Science from Rensselaer Polytechnic Institute, and masters degrees in Aerospace Systems, Space Robotics and Science & Technology Policy from John Hopkins University, MIT and Harvard University, respectively. She also earned a doctorate degree in Aeronautics and Astronautics from MIT.

 

About QinetiQ:

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs more than 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

 

For further information please contact:

Lindsay Walls, Group Director Communications: +44 (0) 7793 427582

Stephen Lamacraft, Interim Group Investor Relations Director: +44 (0) 7920 545841

James Field, Company Secretary: +44 (0) 7841 662957

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZVLFFZBLBFBL
Date   Source Headline
2nd Jun 20266:00 pmRNSHolding(s) in Company
2nd Jun 20267:00 amRNSTransaction in Own Shares
29th May 20264:45 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSQinetiQ Full Year Results 2026
20th May 20264:16 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20264:57 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20269:46 amRNSTransaction in Own Shares
30th Apr 20263:10 pmRNSTotal Voting Rights
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20261:38 pmRNSDirector Declaration
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 202610:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSDirector/PDMR Shareholding
31st Mar 20263:01 pmRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 202611:39 amRNSHolding(s) in Company
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20263:30 pmRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.